- Home
- ENTG vs ASND Comparison
ENTG vs ASND Comparison
Compare ENTG & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTG
- ASND
- Stock Information
- Founded
- ENTG 1966
- ASND 2006
- Country
- ENTG United States
- ASND Denmark
- Employees
- ENTG N/A
- ASND N/A
- Industry
- ENTG Plastic Products
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- ENTG Industrials
- ASND Health Care
- Exchange
- ENTG Nasdaq
- ASND Nasdaq
- Market Cap
- ENTG 11.7B
- ASND 10.6B
- IPO Year
- ENTG 2000
- ASND 2015
- Fundamental
- Price
- ENTG $87.76
- ASND $194.30
- Analyst Decision
- ENTG Strong Buy
- ASND Strong Buy
- Analyst Count
- ENTG 10
- ASND 16
- Target Price
- ENTG $107.30
- ASND $239.88
- AVG Volume (30 Days)
- ENTG 3.3M
- ASND 566.6K
- Earning Date
- ENTG 07-30-2025
- ASND 08-07-2025
- Dividend Yield
- ENTG 0.49%
- ASND N/A
- EPS Growth
- ENTG 60.99
- ASND N/A
- EPS
- ENTG 1.95
- ASND N/A
- Revenue
- ENTG $3,223,108,000.00
- ASND $576,332,355.00
- Revenue This Year
- ENTG $0.64
- ASND $101.37
- Revenue Next Year
- ENTG $9.41
- ASND $76.17
- P/E Ratio
- ENTG $45.01
- ASND N/A
- Revenue Growth
- ENTG N/A
- ASND 54.50
- 52 Week Low
- ENTG $60.75
- ASND $111.09
- 52 Week High
- ENTG $119.95
- ASND $199.99
- Technical
- Relative Strength Index (RSI)
- ENTG 62.75
- ASND 62.30
- Support Level
- ENTG $77.01
- ASND $191.44
- Resistance Level
- ENTG $81.75
- ASND $197.35
- Average True Range (ATR)
- ENTG 3.15
- ASND 7.99
- MACD
- ENTG 1.15
- ASND 0.18
- Stochastic Oscillator
- ENTG 94.36
- ASND 77.06
About ENTG Entegris Inc.
Entegris is a leading supplier of purification solutions and advanced materials. The vast majority of sales are to the semiconductor industry. The majority of revenue comes from semiconductor fabricators, but the company sells to all areas of the semiconductor manufacturing supply chain including equipment and engineering, chemicals and materials, and distributors. Entegris specializes in materials science and materials purity, both of which are crucial in the semiconductor manufacturing process.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.